Decrease in Fracture Rate with Mandatory Bone-protecting Agents in the EORTC 1333/PEACE-3 Trial Comparing Radium-223 Combined with Enzalutamide Versus Enzalutamide Alone: A Safety Analysis
European Urology（2025）
关键词
Bone health,Metastatic castration-resistant prostate cancer,Enzalutamide,Radium-223,Safety analysis,Bone-protecting agents,Bone fractures
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要